Kodiak Sciences Inc. Profile Avatar - Palmy Investing

Kodiak Sciences Inc.

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that …

Biotechnology
US, Palo Alto [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
End of KOD's Analysis
CIK: 1468748 CUSIP: 50015M109 ISIN: US50015M1099 LEI: - UEI: -
Secondary Listings
KOD has no secondary listings inside our databases.